Proposals of statistical consideration to evaluation of results for a specific region in multi‐regional trials – Asian perspective
- 21 June 2010
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 9 (3) , 201-206
Abstract
In recent years, global collaboration has become a conventional strategy for new drug development. To accelerate the development process and to shorten approval time, the design of multi-regional trials incorporates subjects from many countries around the world under the same protocol. After showing the overall efficacy of a drug in all global regions, one can also simultaneously evaluate the possibility of applying the overall trial results to all regions and subsequently support drug registration in each of them. Recently, the trend for simultaneous clinical development in Asian countries being undertaken simultaneously with clinical trials conducted in Europe and the United States has been rapidly rising. In this paper, proposals of statistical consideration to multi-regional trials are provided. More specifically, three aspects are addressed: the definition of the ‘Asian region,’ the consistency criterion between the ‘Asian region’ and the overall regions, and the sample size determination for the multi-regional trial. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 9 references indexed in Scilit:
- Sample Size Determination for a Specific Region in a Multiregional TrialJournal of Biopharmaceutical Statistics, 2010
- Sample size considerations for Japanese patients in a multi‐regional trial based on MHLW guidancePharmaceutical Statistics, 2010
- Sample Size Allocation to Regions in a Multiregional TrialJournal of Biopharmaceutical Statistics, 2009
- Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian PopulationsClinical Pharmacology & Therapeutics, 2008
- An Approach to Rationalize Partitioning Sample Size into Individual Regions in a Multiregional TrialDrug Information Journal, 2008
- Strong Association Between HLA-A*0206 and Stevens-Johnson Syndrome in the JapaneseAmerican Journal of Ophthalmology, 2007
- Genes and the Response to DrugsNew England Journal of Medicine, 2004
- A marker for Stevens–Johnson syndromeNature, 2004
- The origin of Minnan and Hakka, the so‐called “Taiwanese”, inferred by HLA studyTissue Antigens, 2001